Pooled result by fixed model showed that PD-L1 expression had no profound impact on DFS in PD-L1 positive patients with BC (pooled HR:1.40, 95% CI:1.11–1.78, P = .101) (Fig. 2B). This evidence concerns the gene CD274 and breast cancer.